Literature DB >> 16092551

Mood, anxiety and sense of humor in head and neck cancer patients in relation to disease stage, prognosis and quality of life.

Hans Jørgen Aarstad1, Anne Kari H Aarstad, John-Helge Heimdal, Jan Olofsson.   

Abstract

CONCLUSION: At diagnosis, control patients had the lowest depression levels and anxiety scores, followed by those with limited HNSCC disease and these with extended HNSCC disease. Anxiety and depression levels at diagnosis predicted prognosis via an association with extent of disease. Sense of humor, but not anxiety or depression level, predicted lower QoL and depression levels at follow-up.
OBJECTIVE: To study the association between anxiety score, depression level at sense of humor at diagnosis in head and neck squamous cell carcinoma (HNSCC) patients versus TNM stage, prognosis and depression level/quality of life (QOL) 6 years following diagnosis. A control group of patients with benign HN disease was also included.
MATERIAL AND METHODS: Male patients with newly diagnosed HNSCC (n =78) or benign HN (n =61) disease completed the following questionnaires: the Beck Depression Inventory, the Spielberger Trait Anxiety Inventory (state) and the Svebak humor questionnaire. Patients with cachexia or those aged >80 years were excluded. In the HNSCC patients, TNM stage, prognosis and QOL/depression level (n =27) were determined following successful therapy.
RESULTS: HNSCC patients reported high anxiety scores and lower depression levels than control patients, although there was overlap between the groups. N stage was associated with high anxiety scores and depression levels, whereas T stage was only associated with depression levels. Both anxiety scores and depression levels at diagnosis predicted prognosis through an association with TNM stage. Sense of humor, but not depression levels or anxiety scores, at diagnosis predicted QoL and depression levels at follow-up.

Entities:  

Mesh:

Year:  2005        PMID: 16092551     DOI: 10.1080/00016480510027547

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  13 in total

1.  The amount of treatment versus quality of life in patients formerly treated for head and neck squamous cell carcinomas.

Authors:  H J Aarstad; A K H Aarstad; S Lybak; O Monge; D F Haugen; J Olofsson
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-10-05       Impact factor: 2.503

2.  The symptom burden of treatment-naive patients with head and neck cancer.

Authors:  Ehab Y Hanna; Tito R Mendoza; David I Rosenthal; G Brandon Gunn; Pamela Sehra; Emre Yucel; Charles S Cleeland
Journal:  Cancer       Date:  2014-11-04       Impact factor: 6.860

3.  Psychosocial functioning and vascular endothelial growth factor in patients with head and neck cancer.

Authors:  Carolyn Y Fang; Brian L Egleston; John A Ridge; Miriam N Lango; Dana H Bovbjerg; Jamie L Studts; Barbara A Burtness; Margret B Einarson; Andres J P Klein-Szanto
Journal:  Head Neck       Date:  2013-10-26       Impact factor: 3.147

4.  Personality, choice of coping and T stage predict level of distress in head and neck cancer patients during follow-up.

Authors:  Anne K H Aarstad; Elisabeth Beisland; Hans J Aarstad
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-12-27       Impact factor: 2.503

5.  The relationship between weight loss and health-related quality of life in persons treated for head and neck cancer.

Authors:  Barbara A Head; Luke Heitz; Cynthia Keeney; John Myers; Savitri N Appana; Jamie L Studts; Jeffrey Bumpous; Mark Pfeifer
Journal:  Support Care Cancer       Date:  2010-08-21       Impact factor: 3.603

6.  Variability and stability of coping in women with breast cancer.

Authors:  Rafaela Hervatin; Stefanie Sperlich; Heike Koch-Giesselmann; Siegfried Geyer
Journal:  Support Care Cancer       Date:  2011-11-29       Impact factor: 3.603

7.  Quality of life after treatment of laryngeal carcinoma: a single centre cross-sectional study.

Authors:  J S Williamson; D Ingrams; H Jones
Journal:  Ann R Coll Surg Engl       Date:  2011-11       Impact factor: 1.891

8.  Impact of a telehealth intervention on quality of life and symptom distress in patients with head and neck cancer.

Authors:  Mark P Pfeifer; Cynthia Keeney; Jeffrey Bumpous; Tara J Schapmire; Jamie L Studts; John Myers; Barbara Head
Journal:  J Community Support Oncol       Date:  2015-01

9.  Choice of psychological coping in laryngectomized, head and neck squamous cell carcinoma patients versus multiple sclerosis patients.

Authors:  A K H Aarstad; K Lode; J P Larsen; E Bru; H J Aarstad
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-11-18       Impact factor: 2.503

10.  Moderators of the response to a nurse-led psychosocial intervention to reduce depressive symptoms in head and neck cancer patients.

Authors:  Ingeborg C van der Meulen; Anne M May; J Rob J de Leeuw; Ron Koole; Miriam Oosterom; Gert-Jan Hordijk; Wynand J G Ros
Journal:  Support Care Cancer       Date:  2015-01-23       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.